The global ostomy care market size is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.4% during the forecast period. Market growth is driven mainly by factors such as rising incidence of bladder cancer, colorectal cancer, and inflammatory bowel disease; growing geriatric population; a growing number of awareness programs to educate patients regarding the use of ostomy products; technological advancements in ostomy products; and efficient reimbursement system in developed countries are some of the factors driving the growth of the ostomy market.
By product, the ostomy bags segment is expected to hold a major share of the ostomy care market in 2020
Based on the product, the market is categorized into ostomy bags and ostomy accessories. The bags segment is further classified into type, surgery type, and usability. The ostomy bags segment is anticipated to hold major market share over the forecast period owing to the rise in the patient population undergoing ostomy surgeries (either ileostomy, colostomy, or urostomy), technological advancements in the segment, and efficient reimbursement system in developed countries.
By surgery type, the colostomy segment was the largest contributor to the ostomy bags market in 2019
The market for ostomy bags, by surgery type, comprises ileostomy, colostomy, and urostomy. Colostomy accounted for the largest share of the ostomy bags market in 2019. Its large share can be attributed to the rising patient population and growing awareness about ostomy care.
The home care settings end user segment is expected to register significant growth in the near future
In terms of end-users, the ostomy care market is segmented into home care settings, hospitals, and specialty clinics. The growing demand for home healthcare services is supporting the growth of this end-user segment during the forecast period. Moreover, several patients who have undergone colostomy, ileostomy, and urostomy surgeries require ostomy care until the reversal of the surgery or during their lifetime. This has increased the demand for home care services.
Europe stoma/ostomy care market held a major share in 2019
The large share of Europe can be attributed to the growing patient population, rising geriatric population (as this population segment is more prone to developing gastrointestinal diseases which require ostomy procedures), and favorable reimbursement scenario. The population structure of European countries represents low birth rates and higher life expectancy. The rising aging population indicates future increases in the incidence of cancers of the colon and bladder, IBD, and incontinence. Besides, changes in lifestyle, industrialization, changing food habits, and the growing prevalence of smoking have increased the number of ostomy surgeries conducted in Europe. The rapid expansion of healthcare infrastructure across emerging European countries (such as Russia and Poland) will also contribute to the demand for ostomy management products in Europe.
Key Market Players
Coloplast A/S (Denmark), Hollister Incorporated (US), ConvaTec Group plc (UK), B. Braun (Germany), ALCARE Co., Ltd. (Japan), Nu-Hope (US), Marlen Manufacturing & Development Company (US), Welland Medical Limited (UK), Baohe Ostomy Care (China), Flexicare Medical Limited (UK), Cymed (US), Schena Ostomy Technologies, Inc. (US), Perma-Type Company Inc. (US), 3M (US), Smith & Nephew (US), and Salts Healthcare (UK), among others, are the key players in the ostomy care market.
An analysis of the market developments between 2017 and 2020 revealed that several growth strategies such as product launches and enhancements, partnerships, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the ostomy care market. Among these business strategies, product approval and launches, acquisition, partnerships, and agreements were the most widely adopted growth strategies by market players.
Coloplast was the largest player in the ostomy care market in 2019. The company’s leading position in this market can be attributed to its strong pipeline of new products, sustained cost discipline, and adoption of new strategies to enhance its product portfolio based on new technologies available in the market. The Ostomy Care business of the company has witnessed organic sales growth of 7% in 2018-19, which was almost double the overall market growth rate. This growth was mainly supported by the launch of its SenSura Mio product line in various important markets. The company is also focusing on expanding its market presence through M&A activities. For instance, in 2018, the company acquired IncoCare Gunhild Vieler GmbH (Germany).
This research report categorizes the stoma/ostomy care market based on the product, end user, and region.